治疗医药公司(TherapeuticsMD Inc., TXMD)股价周二延续颓势，收盘下跌2.99%至1.14美元，表现明显弱于同业竞争对手。在美股三大指数涨跌互现的交易环境中，该股已连续第四个交易日收阴。
当日纳斯达克综合指数微涨0.18%，收于20677.80点；道琼斯工业平均指数则下跌0.98%，报44023.29点。相较之下，治疗医药公司股价表现明显疲软，较其1月3日创下的52周高点2.44美元已回落53.48%。
与同业公司对比更显弱势：艾伯维公司(AbbVie Inc., ABBV)周二仅下跌1.84%，收于186.39美元。交投数据同样显示市场热度不足，治疗医药公司当日成交量31798手，较其50日平均成交量47511手大幅缩水15713手。
当前股价持续探底态势引发投资者关注，成交量萎缩与同业表现落差共同构成市场对该股的谨慎预期。技术指标显示，股价仍处于深度调整区间，反弹动能尚未显现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.